Show simple item record

dc.contributor.authorYu-Wai-Man, Patrick
dc.contributor.authorNewman, Nancy J
dc.contributor.authorCarelli, Valerio
dc.contributor.authorLa Morgia, Chiara
dc.contributor.authorBiousse, Valérie
dc.contributor.authorBandello, Francesco M
dc.contributor.authorClermont, Catherine Vignal
dc.contributor.authorCampillo, Lorena Castillo
dc.contributor.authorLeruez, Stephanie
dc.contributor.authorMoster, Mark L
dc.contributor.authorCestari, Dean M
dc.contributor.authorForoozan, Rod
dc.contributor.authorSadun, Alfredo
dc.contributor.authorKaranjia, Rustum
dc.contributor.authorJurkute, Neringa
dc.contributor.authorBlouin, Laure
dc.contributor.authorTaiel, Magali
dc.contributor.authorSahel, José-Alain
dc.contributor.authorLHON REALITY Study Group
dc.date.accessioned2022-03-31T16:28:47Z
dc.date.available2022-03-31T16:28:47Z
dc.date.issued2022-04
dc.date.submitted2021-01-29
dc.identifier.issn0950-222X
dc.identifier.others41433-021-01535-9
dc.identifier.other1535
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/335572
dc.descriptionFunder: GenSight Biologics
dc.description.abstractBACKGROUND/OBJECTIVES: REALITY is an international observational retrospective registry of LHON patients evaluating the visual course and outcome in Leber hereditary optic neuropathy (LHON). SUBJECTS/METHODS: Demographics and visual function data were collected from medical charts of LHON patients with visual loss. The study was conducted in 11 study centres in the United States of America and Europe. The collection period extended from the presymptomatic stage to at least more than one year after onset of vision loss (chronic stage). A Locally Weighted Scatterplot Smoothing (LOWESS) local regression model was used to analyse the evolution of best-corrected visual acuity (BCVA) over time. RESULTS: 44 LHON patients were included; 27 (61%) carried the m.11778G>A ND4 mutation, 8 (18%) carried the m.3460G>A ND1 mutation, and 9 (20%) carried the m.14484T>C ND6 mutation. Fourteen (32%) patients were under 18 years old at onset of vision loss and 5 (11%) were below the age of 12. The average duration of follow-up was 32.5 months after onset of symptoms. At the last observed measure, mean BCVA was 1.46 LogMAR in ND4 patients, 1.52 LogMAR in ND1 patients, and 0.97 LogMAR in ND6 patients. The worst visual outcomes were reported in ND4 patients aged at least 15 years old at onset, with a mean BCVA of 1.55 LogMAR and no tendency for spontaneous recovery. The LOESS modelling curve depicted a severe and permanent deterioration of BCVA. CONCLUSIONS: Amongst LHON patients with the three primary mtDNA mutations, adult patients with the m.11778G>A ND4 mutation had the worst visual outcomes, consistent with prior reports.
dc.languageen
dc.publisherSpringer Science and Business Media LLC
dc.subjectAdolescent
dc.subjectAdult
dc.subjectDNA, Mitochondrial
dc.subjectEurope
dc.subjectHumans
dc.subjectMutation
dc.subjectOptic Atrophy, Hereditary, Leber
dc.subjectRetrospective Studies
dc.titleNatural history of patients with Leber hereditary optic neuropathy-results from the REALITY study.
dc.typeArticle
dc.date.updated2022-03-31T16:28:47Z
prism.endingPage826
prism.issueIdentifier4
prism.publicationNameEye (Lond)
prism.startingPage818
prism.volume36
dc.identifier.doi10.17863/CAM.83003
dcterms.dateAccepted2021-04-01
rioxxterms.versionofrecord10.1038/s41433-021-01535-9
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidYu-Wai-Man, Patrick [0000-0001-7847-9320]
dc.contributor.orcidJurkute, Neringa [0000-0002-3092-7451]
dc.contributor.orcidTaiel, Magali [0000-0003-1139-5178]
dc.identifier.eissn1476-5454
pubs.funder-project-idNational Institute for Health Research (IS-BRC-1215-20014)
cam.issuedOnline2021-04-28


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record